Royal Pharmaceutical Society (RPS) - News updates

Commenting on the proposed review of polypharmacy ordered by the Health and Social Care Secretary, Chair of the English Pharmacy Board Sandra Gidley said: ‘’Pharmacists across the health

Making sure pharmacists are able to provide patients with the medicines they need is our priority. Pharmacists are already helping patients to get hold of medicines in short supply every day. We ar

NHS Improvement has issued a patient safety alert for the safer temporary identification criteria for unknown or unidentified patients for all organisations with emergency departments.

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a precautionary recall of all affected batches of Valsartan containing medicines made by Mylan and Teva UK Limited. This is du

Supporting guidance for the prescribing of gluten-free foods in Primary Care has been issued by NHS England.

The UK imports 37 million packs of medicine each month from the EU - and exports even more. RPS President Ash Soni was interviewed today about access to medicines in case ofa no-deal Brexit on the BB

The interim protocol on dispensing of adrenaline auto-injectors, 150microgram will no longer be in effect from Thursday 29th November 2018.

Responding to the announcement today from the Department of Health and Social Care that ‘community-based rapid response teams’ and dedicated support for care home residents will involve ph

The recent judicial review ruling finds the use of Avastin (bevacizumab) in the NHS for the treatment of wet AMD to be lawful. Whilst we recognise the financial savings that could be made by switching

NHS England has published additional guidance to clinicians: Cannabis-based products for medicinal use, which is endorsed by the Scottish Government, Department of Health Northern Ireland and Welsh Go